Genelux (GNLX) Revenue (2022 - 2024)

Genelux (GNLX) recorded quarterly Revenue of $8000.0 in Q1 2024, down 95.29% quarter-over-quarter from $170000.0 in Q1 2023, and down 95.29% on a YoY basis from $170000.0 in Q2 2023.

Genelux (GNLX) Revenue (2022 - 2024) Analysis & Trends

Genelux's Revenue history runs 3 years deep, the most recent figure standing at $8000.0 for Q1 2024.

  • In Q1 2024, Revenue fell 95.29% year-over-year to $8000.0; the TTM figure through Dec 2024 stood at $8000.0 (down 95.29% YoY), while the FY2025 annual figure was $8000.0, changed 0.0% from the prior year.
  • Revenue was $8000.0 for Q1 2024 at Genelux, down from $170000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $11.0 million in Q3 2022 to a low of -$10.8 million in Q4 2022.
  • Historically, Revenue has averaged $87000.0 across 3 years, with a median of $89000.0 in 2023.
  • Biggest YoY gain for Revenue was 95.29% in 2024; the steepest drop was 95.29% in 2024.
  • A 3-year view of Revenue shows it stood at -$10.8 million in 2022, then surged by 101.57% to $170000.0 in 2023, then slumped by 95.29% to $8000.0 in 2024.
  • The last three Revenue figures came in at $8000.0 (Q1 2024), $170000.0 (Q1 2023), and -$10.8 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Genelux 129.36 Mn 129.36 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2024 8,000.00
Mar 31, 2023 170,000.00
Dec 31, 2022 -10.83 Mn
Sep 30, 2022 11.00 Mn